Background Fatigue prevalence and severity have been assessed in a variety of studies,
yet, not in a standardized way, and predominantly in breast cancer patients. Systematic …

Background: Fatigue is disabling and continuous phenomenon in cancer patients during
and after various anticancer treatments which can continue for many years after treatment …

Fatigue is among the most commonly reported symptoms of patients with cancer, with
prevalence exceeding 60% in many studies. It is among the most distressing symptoms …

Fatigue is a highly prevalent condition among cancer patients. Although most cancer
patients report that fatigue is a major obstacle to maintaining normal daily activities and …

Opinion statement Cancer-related fatigue (CRF) is a problem for a significant proportion of
cancer survivors during and after active cancer treatment. However, CRF is underdiagnosed …

BACKGROUND Although fatigue is one of the most common complaints of patients with
cancer, it went unrecognized or overlooked for many years, until clinicians achieved better …

Fatigue can be a prevalent and serious problem for the individual with cancer and can
negatively impact on the individual's quality of life. Little is known about the prevalence of …

This aim of this systematic review was to determine the prevalence and pattern of cancer-
related fatigue (CRF), and identify factors associated with its development. Relevant …

Background: Fatigue in cancer is very common and can be experienced at all stages of
disease and in survivors. There is no accepted definition of cancer-related fatigue (CRF) and …

CONTEXT: There is a lack of longitudinal studies investigating fatigue from before cancer
treatment to long after successful cancer treatment. OBJECTIVES: This prospective follow-up …